NXGEN MDX Trademark

Trademark Overview

On Wednesday, October 11, 2023, a trademark application was filed for NXGEN MDX with the United States Patent and Trademark Office. The USPTO has given the NXGEN MDX trademark a serial number of 98218466. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, September 12, 2024. This trademark is owned by NxGen MDx, LLC. The NXGEN MDX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic counseling; Genetic testing for medical purposes; Testing for medical diagnostic or treatment purposes in the field of infectious diseases
nxgen mdx

General Information

Serial Number98218466
Word MarkNXGEN MDX
Filing DateWednesday, October 11, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkNEXT GENERATION MD X
Goods and ServicesGenetic counseling; Genetic testing for medical purposes; Testing for medical diagnostic or treatment purposes in the field of infectious diseases
NOT AVAILABLEMDX

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2023
Primary Code044
First Use Anywhere DateThursday, February 21, 2013
First Use In Commerce DateThursday, February 21, 2013

Trademark Owner History

Party NameNxGen MDx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGrand Rapids, MI 49504

Trademark Events

Event DateEvent Description
Wednesday, October 11, 2023NEW APPLICATION ENTERED
Friday, December 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 29, 2024ASSIGNED TO EXAMINER
Wednesday, June 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024NON-FINAL ACTION WRITTEN
Friday, August 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2024LETTER OF SUSPENSION E-MAILED
Thursday, September 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 12, 2024SUSPENSION LETTER WRITTEN

Related Keywords

nxgen genetic medical purposes testing infectious diseases field treatment counseling diagnostic